Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Free Cash Flow: 2012-2025

Historic Free Cash Flow for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $42.0 million.

  • Veracyte's Free Cash Flow rose 51.38% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.2 million, marking a year-over-year increase of 73.88%. This contributed to the annual value of $63.8 million for FY2024, which is 86.24% up from last year.
  • Veracyte's Free Cash Flow amounted to $42.0 million in Q3 2025, which was up 29.85% from $32.3 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Free Cash Flow ranged from a high of $42.0 million in Q3 2025 and a low of -$41.8 million during Q1 2021.
  • Over the past 3 years, Veracyte's median Free Cash Flow value was $13.6 million (recorded in 2023), while the average stood at $16.0 million.
  • In the last 5 years, Veracyte's Free Cash Flow tumbled by 898.06% in 2022 and then surged by 574.52% in 2023.
  • Veracyte's Free Cash Flow (Quarterly) stood at $7.6 million in 2021, then climbed by 3.51% to $7.9 million in 2022, then spiked by 65.84% to $13.1 million in 2023, then skyrocketed by 56.13% to $20.4 million in 2024, then spiked by 51.38% to $42.0 million in 2025.
  • Its last three reported values are $42.0 million in Q3 2025, $32.3 million for Q2 2025, and $3.5 million during Q1 2025.